NCT01302496
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- UZ Brussel Jette, Brabant, Belgium
Clinical trial condition
Nevi and Melanomas
Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.
2,368 public trials
407 recruiting studies
Nevi and Melanomas trial results
Completed
Cytogenetic Study of Ocular Melanoma
NCT00344799
- Conditions
- Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +12 more
- Locations
-
- Jules Stein Eye Institute Los Angeles, California, United States
NCT02110355
- Conditions
- Advanced Malignancy, Advanced Solid Tumors, Cancer, +15 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Boston, Massachusetts, United States
- Research Site Chapel Hill, North Carolina, United States
NCT02085070
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +25 more
- Locations
-
- Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States
Completed
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
NCT01967823
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01763164
- Conditions
- Melanoma, Metastatic or Unresectable Cutaneous Melanoma, Neoplasm Metastasis, +14 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- Florida Cancer Specialists Altamonte Springs, Florida, United States
- Florida Cancer Specialists Bonita Springs, Florida, United States
NCT00303251
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- James Graham Brown Cancer Center Louisville, Kentucky, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- MD Anderson Cancer Houston, Texas, United States
Completed
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT02854657
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- June K Robinson Chicago, Illinois, United States
NCT01178411
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
- Locations
-
Not specified